David Marcilla

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Josefina Cruz, Nicolas Penel et al. · The Lancet Oncology · 2020 · 84 citations

Surgical Oncology, Medicine, Systemic Treatment +5

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

Javier Martín‐Broto, Andrés Redondo, Claudia Valverde et al. · Annals of Oncology · 2017 · 57 citations · Full text

Spanish Group, Osteosarcoma Patients, Oncology +7

Lower Extremity Fibro-Adipose Vascular Anomaly (FAVA): A New Case of a Newly Delineated Disorder

Israel Fernández‐Pineda, David Marcilla, Francisco Javier Downey-Carmona et al. · Annals of Vascular Diseases · 2014 · 42 citations · Full text

Obesity, Metabolic Syndrome, Fibrosis +12

Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A

Javier Martín‐Broto, Jerónimo Martínez-García, David S. Moura et al. · Signal Transduction and Targeted Therapy · 2023 · 33 citations · Full text

Hippo pathway effectors YAP1/TAZ induce an <i>EWS–FLI1</i> ‐opposing gene signature and associate with disease progression in Ewing sarcoma

Pablo Rodríguez‐Núñez, Laura Romero‐Pérez, Ana Teresa Amaral et al. · The Journal of Pathology · 2019 · 31 citations · Full text